EQS-Adhoc: CompuGroup Medical Administrative Board appoints Michael Rauch as CEO
|
EQS-Ad-hoc: CompuGroup Medical SE & Co. KGaA / Key word(s): Personnel
CompuGroup Medical Administrative Board appoints Michael Rauch as CEO
17-May-2023 / 08:31 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
At its meeting prior to today’s Annual General Meeting, the Administrative Board of CompuGroup Medical Management SE, general partner of CompuGroup Medical SE & Co. KGaA (CGM), one of the world’s leading e-health providers, appointed Michael Rauch, the current Speaker for the Managing Directors and longtime Chief Financial Officer (CFO), as Chief Executive Officer (CEO), effective immediately.
The search for a successor for the CFO position will be initiated immediately, Michael Rauch will continue to perform the CFO role additionally in the interim period.
End of Inside Information
17-May-2023 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com
|
| Language: |
English |
| Company: |
CompuGroup Medical SE & Co. KGaA |
|
Maria Trost 21 |
|
56070 Koblenz |
|
Germany |
| Phone: |
+49 (0)160 3630362 |
| Fax: |
+49 (0)261 8000 3200 |
| E-mail: |
[email protected] |
| Internet: |
www.cgm.com |
| ISIN: |
DE000A288904 |
| WKN: |
A28890 |
| Indices: |
SDAX, TecDAX |
| Listed: |
Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: |
1634797 |
| |
| End of Announcement |
EQS News Service |
1634797 17-May-2023 CET/CEST
|
Die wichtigsten Finanzdaten auf einen Blick
|
| |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023e |
| Umsatzerlöse1 |
582,38 |
717,02 |
745,81 |
837,26 |
1.025,32 |
1.129,74 |
1.187,66 |
| EBITDA1,2 |
128,44 |
187,84 |
178,13 |
197,48 |
213,39 |
216,35 |
229,76 |
| EBITDA-Marge3 |
22,05 |
26,20 |
23,88 |
23,59 |
20,81 |
19,15 |
|
| EBIT1,4 |
90,07 |
143,23 |
115,27 |
121,77 |
102,68 |
104,03 |
113,96 |
| EBIT-Marge5 |
15,47 |
19,98 |
15,46 |
14,54 |
10,01 |
9,21 |
9,60 |
| Jahresüberschuss1 |
31,74 |
96,34 |
66,15 |
73,42 |
69,03 |
74,12 |
46,87 |
| Netto-Marge6 |
5,45 |
13,44 |
8,87 |
8,77 |
6,73 |
6,56 |
3,95 |
| Cashflow1,7 |
85,82 |
136,35 |
110,50 |
149,93 |
165,27 |
145,03 |
179,53 |
| Ergebnis je Aktie8 |
0,63 |
1,92 |
1,33 |
1,40 |
1,30 |
1,40 |
0,88 |
| Dividende8 |
0,35 |
0,50 |
0,50 |
0,50 |
0,50 |
0,50 |
0,35 |
Quelle: boersengefluester.de und Firmenangaben
Geschäftsbericht 2023 - Kostenfrei herunterladen. 
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de
Wirtschaftsprüfer: KPMG
|
| INVESTOR-INFORMATIONEN |
| ©boersengefluester.de |
| CompuGroup Medical |
| WKN |
Kurs in € |
Einschätzung |
Börsenwert in Mio. € |
| A28890 |
28,500 |
Halten |
1.531,44 |
| KGV 2025e |
KGV 10Y-Ø |
BGFL-Ratio |
Shiller-KGV |
| 21,92 |
35,77 |
0,61 |
24,46 |
| KBV |
KCV |
KUV |
EV/EBITDA |
| 2,49 |
8,53 |
1,29 |
9,62 |
| Dividende '22 in € |
Dividende '23e in € |
Div.-Rendite '23e
in % |
Hauptversammlung |
| 0,50 |
1,00 |
3,51 |
22.05.2024 |
| Q1-Zahlen |
Q2-Zahlen |
Q3-Zahlen |
Bilanz-PK |
| 08.05.2024 |
08.08.2024 |
07.11.2024 |
28.03.2024 |
| Abstand 60Tage-Linie |
Abstand 200Tage-Linie |
Performance YtD |
Performance 52 Wochen |
| -5,57% |
-21,42% |
-24,80% |
-42,75% |
|
|
CompuGroup Medical SE & Co. KGaA DE000A288904